CoChat

Glutamic acid decarboxylase and glutamate receptor changes during tolerance and dependence to benzodiazepines

Open access
Izzo, Emanuela, Auta, James, Impagnatiello, Francesco, Pesold, Christine, Guidotti, Alessandro, Costa, Erminio · 2001 · Proceedings of the National Academy of Sciences

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Abstract

Protracted administration of diazepam elicits tolerance, whereas discontinuation of treatment results in signs of dependence. Tolerance to the anticonvulsant action of diazepam is present in an early phase (6, 24, and 36 h) but disappears in a late phase (72–96 h) of withdrawal. In contrast, signs of dependence such as decrease in open-arm entries on an elevated plus-maze and increased susceptibility to pentylenetetrazol-induced seizures were apparent 96 h (but not 12, 24, or 48 h) after diazepam withdrawal. During the first 72 h of withdrawal, tolerance is associated with changes in the expression of GABA A (γ-aminobutyric acid type A) receptor subunits (decrease in γ 2 and α 1 ; increase in α 5 ) and with an increase of mRNA expression of the most abundant form of glutamic acid decarboxylase (GAD), GAD 67 . In contrast, dl -α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor GluR1 subunit mRNA and cognate protein, which are normal during the early phase of diazepam withdrawal, increase by approximately 30% in cortex and hippocampus in association with the appearance of signs of dependence 96 h after diazepam withdrawal. Immunohistochemical studies of GluR1 subunit expression with gold-immunolabeling technique reveal that the increase of GluR1 subunit protein is localized to layer V pyramidal neurons and their apical dendrites in the cortex, and to pyramidal neurons and in their dendritic fields in hippocampus. The results suggest an involvement of GABA-mediated processes in the development and maintenance of tolerance to diazepam, whereas excitatory amino acid-related processes (presumably via AMPA receptors) may be involved in the expression of signs of dependence after withdrawal.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.051628698

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 33 references

Research works printed but not linked: 11

  1. J H Woods, L A Katz, G Winger Pharmacol Rev 44, 151–347 (1992).
  2. E Costa, J Auta, A Guidotti Handbook of Experimental Pharmacology: Pharmacology of Inhibitory Amino Acid Transmitters, ed H Möhler (Springer, Berlin) 150, 227–250 (2000).
  3. G P Ryan, N R Boisse J Pharmacol Exp Ther 226, 100–107 (1983).
  4. F Impagnatiello, C Pesold, P Longone, H Caruncho, J M Fritschy, E Costa, A Guidotti Mol Pharmacol 49, 822–831 (1996).
  5. T J Zhao, T H Chiu, H C Rosenberg Mol Pharmacol 45, 657–663 (1994).
  6. R J Primus, J Yu, J Xu, C Hartnett, M Meyyappan, C Kostas, T V Ramabhadran, D W Gallager J Pharmacol Exp Ther 276, 882–890 (1996).
  7. D W Gallager, R J Primus Biochem Soc Symp 59, 135–151 (1993).
  8. J Auta, E Romeo, A Kozikowski, D Ma, E Costa, A Guidotti J Pharmacol Exp Ther 265, 649–656 (1993).
  9. J Auta, P Giusti, A Guidotti, E Costa J Pharmacol Exp Ther 270, 1262–1269 (1994).
  10. D R Grayson, S Ikonomovic Neuromethods 34, 127–151 (1998).
  11. J H Eberwine Dendrites, eds G Stuart, N Spruston, M Hausser (Oxford Univ. Press, New York), pp. 35–67 (1999).

Cited by

See all 96

Metadata

Authors
Izzo, E., Auta, J., Impagnatiello, F., Pesold, C., Guidotti, A., & Costa, E.
Affiliations
University of Illinois Chicago (US)
Venue
Proceedings of the National Academy of Sciences
Published
2001-03-13
Volume
98
Issue
6
Pages
3483-3488
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2068003831
Cited by
90
References
33
Citations by year
2026: 5 · 2025: 3 · 2023: 3 · 2022: 2 · 2021: 1 · 2019: 1 · 2018: 2 · 2017: 1 · 2016: 3 · 2015: 3 · 2014: 3 · 2013: 3 · 2012: 3
FWCI
1.84
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • University of California, Los Angeles
  • National Institute of Mental Health (MH 49486, MH-56500, R01MH056500, R01MH049486)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
benzodiazepine dependence, diazepam withdrawal, glutamic acid decarboxylase, GAD67, GABAA receptor subunits, glutamate receptors, excitatory amino acids, pentylenetetrazole-induced seizures, elevated plus maze, pyramidal neurons, hippocampus, cerebral cortex
MeSH terms
Animals, Brain, Diazepam, Drug Tolerance, Frontal Lobe, Glutamate Decarboxylase, Hippocampus, Isoenzymes, Male, Occipital Lobe, Rats, Inbred F344, RNA, Messenger, Time Factors, Receptors, AMPA, GABA Modulators, Substance-Related Disorders, Gene Expression Profiling, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Glutamic acid decarboxylase and glutamate receptor changes during tolerance and dependence to benzodiazepines. https://app.cochat.ai/papers/10.1073/pnas.051628698
The paper
Izzo, E., Auta, J., Impagnatiello, F., Pesold, C., Guidotti, A., & Costa, E. (2001). Glutamic acid decarboxylase and glutamate receptor changes during tolerance and dependence to benzodiazepines. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.051628698

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.